Skip to main content
. 2019 Feb 18;46(3):223–240. doi: 10.1007/s10928-019-09622-x

Fig. 4.

Fig. 4

Left: semi-logarithmic plot of concentration–time data of test-compound A at three oral doses (0.3, 3 and 30 mg·kg−1, shown as dotted, dashed and solid lines, respectively) in Sprague–Dawley rats from Study 2. Test compound was administered 2 h before intravenous challenge with LPS. The dashed red horizontal line represents the model-predicted test compound potency of about 20 nM. Right: Dose-normalized test compound concentrations plotted versus time